Rafael Marcos‐gragera - Epidemiology

Author Information

Rafael Marcos-Gragera is a distinguished epidemiologist associated with the Epidemiology Unit and Girona Cancer Registry at the Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology in Girona, Spain. His work primarily focuses on cancer epidemiology, with a keen interest in the registration and analysis of cancer data to improve understanding and management of the disease across different populations.

Research Contributions

Rafael Marcos-Gragera has contributed significantly to the field of epidemiology, particularly in cancer research. His recent studies include a wide range of topics such as the registration of urothelial tumors in cancer registries, morphological analysis of cutaneous melanoma, incidence studies of myeloid and hematological neoplasms in Spain, and global survival trends for leukemia in young populations. His research also extends to predictive modeling for ovarian cancer burdens and analyses of trends in human papillomavirus-related oropharyngeal cancer. His work often involves collaborative studies that utilize population-based data to enhance the understanding of cancer epidemiology and survival outcomes worldwide.

Aliases

Rafael Marcos-Gragera is also known by several aliases, including R Marcos-gragera, R. Marcos-gragera, and Rafael Marcos–gragera.

Publication and Citation Metrics

Metric	Value
Citation Count	13,078
h-index	45
Paper Count	264

Publications:

Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?

DOI: 10.3390/ijerph19052714

Year: 2022

Does the morphology of cutaneous melanoma help explain the international differences in survival? Results from 1,578,482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).

DOI: 10.1111/bjd.21274

Year: 2022

Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registries

DOI: 10.1038/s41598-021-03734-6

Year: 2022

Estimates of the incidence of hematological neoplasms in Spain, 2021: Study of the Spanish Network of Cancer Registries (REDECAN)

DOI: 10.1016/j.medcle.2021.09.011

Year: 2022

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.

DOI: 10.1016/s2352-4642(22)00095-5

Year: 2022

Predicting Ovarian-Cancer Burden in Catalonia by 2030: An Age–Period–Cohort Modelling

DOI: 10.3390/ijerph19031404

Year: 2022

No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach

DOI: 10.3390/ijerph19063605

Year: 2022

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

DOI: 10.3390/cancers14030780

Year: 2022

Bayesian variable selection and survival modeling: assessing the Most important comorbidities that impact lung and colorectal cancer survival in Spain

DOI: 10.1186/s12874-022-01582-0

Year: 2022

Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe

DOI: 10.3390/ijerph19084802

Year: 2022

How does Interdisciplinary Collaboration Enhance Outcomes?

Why are Dilated Eye Exams Important in Public Health?

Why are Endospores Important in Epidemiology?

Why are Anticoagulants Important in Epidemiology?

What Role Does Data Confidentiality Play?

What are the Applications of Edge Computing in Epidemiology?

What is Knowledge Uptake in Epidemiology?

What are the Symptoms of CWD?

Why is External Validation Important?

Can Airflow Patterns be Modified to Reduce Disease Spread?

Partnered Content Networks

Relevant Topics